The impact of combination therapy with peginterferon alfa-2a and ribavirin on the energy intake and body weight of adult hepatitis C patients

Journal of Human Nutrition and Dietetics

Volumn 21, Issue 5, 2008, Pages 486-493

  Hamer, C ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Energy intake; Hepatitis C; Interferon; Nutritional status; Ribavirin; Weight

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; AGED; APPETITE; APPETITE DISORDER; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; FATIGUE; FEMALE; HEPATITIS C; HUMAN; MALE; NAUSEA; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

AGED; ANTIVIRAL AGENTS; APPETITE; BODY MASS INDEX; BODY WEIGHT; DRUG THERAPY, COMBINATION; ENERGY INTAKE; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; NAUSEA; POLYETHYLENE GLYCOLS; QUESTIONNAIRES; RIBAVIRIN;

HEPATITIS C VIRUS;

EID: 51649122024     PISSN: 09523871     EISSN: 1365277X     Source Type: Journal    
DOI: 10.1111/j.1365-277X.2008.00882.x     Document Type: Article

References (23)

1. Bingham, S.A. & Nelson, M. (1991) Design Concepts in Nutritional Epidemiology. Oxford: Oxford University Press.
2. Davis, G.L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S.C., Trepo, C., Shiffman, M.L., Zeuzem, S., Craxi, A., Ling, M.H. & Albrecht, J. for the International Hepatitis Interventional Therapy Group (1998) Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N. Engl. J. Med. 339, 1493-1499.
3. Di Bisceglie, A.M. & Hoofnagle, J.H. (2002) Optimal therapy of hepatitis C. Hepatology 36, 121-127.
4. Fried, M.W. (2002b) Side effects of therapy of hepatitis C and their management. Hepatology 36, 237-244.
5. Fried, M.W., Schiffman, M.L., Reddy, R., Smith, C., Marinos, G., Goncales, F.L., Haussinger, D., Diago, M., Carosi, G., Dhumeaux, D., Craxi, A., Lin, A., Hoffman, J. & Yu, J. (2002a) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. NEJM 347, 975-982.
6. Garcia-Benayas, T., Blanco, F. & Soriano, V. (2002) Weight loss in HIV-infected patients. N. Engl. J. Med. 343, 1287-1288.
7. Gersovitz, M., Madden, J.P. & Smiciklas-Wright, H. (1978) Validity of the 24hour dietary recall and 7day record for group comparisons. J. Am. Diet. Assoc. 73, 48-55.
8. Gift, A.G. (1989) Visual analogue scales: Measurement of subjective phenomena. Nurs. Res. 38, 286-288.
9. Glue, P., Fang, J.W.S., Rouzier-Panis, R., Raffanel, C., Sabo, R., Gupta, S.K., Salfi, M. & Jacobs, A. and the Hepatitis C Intervention Therapy Group (2000) Pegylated interferon-a2b: Pharmokinetics, pharmacodynamics, safety, and preliminary efficacy date. Clin. Pharmacol. Ther. 68, 556-567.
10. Goldberg, G.R., Black, A.E., Jebb, S.A., Cole, T.J., Murgatroyd, P.R., Coward, W.A. & Prentice, A.M. (1991) Critical evaluation of energy intake data using fundamental principles of energy physiology: 1. Derivation of cut-off limits to identify under-reporting. Eur. J. Clin. Nut. 45, 569-581.
11. Gottrand, F., Michaud, L., Guimber, D., Ategbo, S., Dubar, G., Turck, D. & Farriaux, J.P. (1996) Influence of recombinant interferon alpha on nutritional status and growth pattern in children with chronic viral hepatitis. Eur. J. Pediatr. 155, 1031-1034.
12. Gow, P.J. & Mutimer, D. (2001) Treatment of chronic hepatitis. BMJ 323, 1164-1167.
13. Huskisson, E.C. (1974) Measurement of pain. Lancet 2, 1127-1131.
14. Kroke, A., Klipstein-Grobusch, K. & Voss, S. (1999) Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: Comparison of energy, protein and macronutrient intakes estimated with the doubly labelled water, urinary nitrogen, and repeated 24-h dietary recall methods. Am. J. Clin. Nutr. 70, 439-447.
15. Lebensztejn, D.M., Zagorecka, E., Kaczmarski, M. & Piotrowska-Jastrzebska, J. (2001) The assessment of nutritional status in children with chronic hepatitis B treated with interferon alpha. Polski Merkuriusz Lekarski 11, 29-31.
16. Macdiarmid, J.I. & Blundell, J.E. (1997) Dietary under-reporting: what people say about recording their food intake. Eur. J. Clin. Nutr. 51, 199-200.
17. Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, M., Reindollar, R., Goodman, Z.D., Koury, K., Ling, M.H. & Albrecht, J.K., and the International Hepatitis Interventional Therapy Group. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 358, 958-965.
18. Ministry of Agriculture Fisheries and Food. (1996) Food Portion Sizes, 2nd edn. London: HMSO.
19. Murphy, D.F., McDonald, A., Power, C., Unwin, A. & MacSullivan, R. (1987) Measurement of pain: A comparison of the visual analogue with a nonvisual analogue scale. Clin. J. Pain 3, 197-199.
20. National Institute for Clinical Excellence Technology. (2004) National Institute for Clinical Excellence Technology Appraisal 75 January 2004. Available at: http://www.nice.org.uk/guidance (accessed on February 2004).
21. Perez-Olmeda, M., Nunez, M., Romero, M., Gonzalez, J., Castro, A., Arribas, J.R., Pedreira, J., Barreiro, P., Garcia-Samaniego, J., Martin-Carbonero, L., Jimenez-Nacher, I. & Soriano, V. (2003) Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 17, 1023-1028.
22. Schofield, W.N, Schofield, C. & James, W.P.T. (1985) Basal metabolic rate-review and prediction. Hum. Nutr. Clin. Nutr. 39 (Suppl. 1), 1-96.
23. World Health Organization. (2000) WHO Fact Sheet No. 164, Oct 2000. Available at: http://www.who.int/entity/mediacentre/factsheets/fs164/en (accessed on February 2004).